119 related articles for article (PubMed ID: 38608350)
1. White matter hyperintensities mediate the association between frailty and cognitive impairment in moyamoya disease.
Du J; Qu C; Xu Z; Liu Z; Lv M; Wang D; Wei W; Duan Y; Shen J
Clin Neurol Neurosurg; 2024 May; 240():108283. PubMed ID: 38608350
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
[TBL] [Abstract][Full Text] [Related]
3. Association between White Matter Hyperintensities Burden and Cognitive Function in Adult Asymptomatic Moyamoya Disease.
Shen J; Xu Z; Liu Z; Duan Y; Wei W; Chang J
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769790
[No Abstract] [Full Text] [Related]
4. Characteristics and Clinical Implication of White Matter Lesions in Patients With Adult Moyamoya Disease.
Yang W; Jung KH; Kang DW; Lee EJ; Jeong HY; Chung M; Kim Y; Ha J; Kim JM; Lee SH
Neurology; 2023 May; 100(18):e1912-e1921. PubMed ID: 36878709
[TBL] [Abstract][Full Text] [Related]
5. Cross-Sectional Association Between Cognitive Frailty and White Matter Hyperintensity Among Memory Clinic Patients.
Sugimoto T; Ono R; Kimura A; Saji N; Niida S; Toba K; Sakurai T
J Alzheimers Dis; 2019; 72(2):605-612. PubMed ID: 31594230
[TBL] [Abstract][Full Text] [Related]
6. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
[TBL] [Abstract][Full Text] [Related]
7. Pathways linking regional hyperintensities in the brain and slower gait.
Bolandzadeh N; Liu-Ambrose T; Aizenstein H; Harris T; Launer L; Yaffe K; Kritchevsky SB; Newman A; Rosano C
Neuroimage; 2014 Oct; 99():7-13. PubMed ID: 24841418
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
[No Abstract] [Full Text] [Related]
9. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
[TBL] [Abstract][Full Text] [Related]
10. Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities.
Veldsman M; Kindalova P; Husain M; Kosmidis I; Nichols TE
Neuroimage Clin; 2020; 28():102405. PubMed ID: 32971464
[TBL] [Abstract][Full Text] [Related]
11. Differential Influence of Location-Specific White-Matter Hyperintensities on Attention Subdomains Measured Using the Attention Network Test.
Wang B; Zhang J; Pan W; Cao S; Li B; Bai L; Hu P; Tian Y; Jiang D; Wang K
Med Sci Monit; 2020 Jan; 26():e921874. PubMed ID: 31940305
[TBL] [Abstract][Full Text] [Related]
12. Exploring the relationship between frailty and executive dysfunction: the role of frontal white matter hyperintensities.
Pozo N; Romero C; Andrade M; Délano PH; Medel V; Troncoso M; Orellana P; Rodriguez MI; Fabres C; Delgado C
Front Aging Neurosci; 2023; 15():1196641. PubMed ID: 37711991
[TBL] [Abstract][Full Text] [Related]
13. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
[TBL] [Abstract][Full Text] [Related]
14. Associations between microstructural tissue changes, white matter hyperintensity severity, and cognitive impairment: an intravoxel incoherent motion imaging study.
Lin H; Dai X; Su J; Yang S; Zheng Y; Ma M; Yu S
Front Aging Neurosci; 2023; 15():1258105. PubMed ID: 38094505
[TBL] [Abstract][Full Text] [Related]
15. Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Okita M; Shimizu S; Kanetaka H; Umahara T; Sakurai H; Hanyu H
Geriatr Gerontol Int; 2019 Oct; 19(10):1036-1040. PubMed ID: 31489777
[TBL] [Abstract][Full Text] [Related]
16. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
[TBL] [Abstract][Full Text] [Related]
17. Interplay of White Matter Hyperintensities, Cerebral Networks, and Cognitive Function in an Adult Population: Diffusion-Tensor Imaging in the Maastricht Study.
Vergoossen LWM; Jansen JFA; van Sloten TT; Stehouwer CDA; Schaper NC; Wesselius A; Dagnelie PC; Köhler S; van Boxtel MPJ; Kroon AA; de Jong JJA; Schram MT; Backes WH
Radiology; 2021 Feb; 298(2):384-392. PubMed ID: 33350892
[TBL] [Abstract][Full Text] [Related]
18. Alteration of regional homogeneity and white matter hyperintensities in amnestic mild cognitive impairment subtypes are related to cognition and CSF biomarkers.
Luo X; Jiaerken Y; Huang P; Xu XJ; Qiu T; Jia Y; Shen Z; Guan X; Zhou J; Zhang M;
Brain Imaging Behav; 2018 Feb; 12(1):188-200. PubMed ID: 28236166
[TBL] [Abstract][Full Text] [Related]
19. Systemic oxidative stress and cognitive function in Parkinson's disease with different PWMH or DWMH lesions.
Chang TC; Chen YC; Huang YC; Lin WC; Lu CH
BMC Neurol; 2021 Jan; 21(1):16. PubMed ID: 33430806
[TBL] [Abstract][Full Text] [Related]
20. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
